Clinical Trials in China / NCT06162234
Recruiting
Observational
Wuhan High Myopia Study
NCT06162234 · tracked via the Priya Life Science China tracker
Condition(s) studied
High Myopia
Investigational drug(s) / intervention(s)
observational
observational: none (observational study)
Study summary
The study aims to observe the long-term changes of ocular（especially fundus） structure and visual function in patients with high myopia, so as to provide evidence for the prevention, diagnosis and prognosis of high myopia.
Eligibility
Inclusion Criteria:
* Voluntarily sign informed consent;
* Commit to follow the research procedures and cooperate with the whole process of the study;
* Age ≥18 years old;
* Best corrected visual acuity ≥0.1;
* Spherical Equivalent Refraction≤-6.00D or axial length ≥26mm in high myopia group；
Exclusion Criteria:
* Unable or unwilling to sign informed consent;
* Unable to cooperate with the examination;
* Astigmatism ≤-1.5D；
* Patients with refractive interstitial opacity so that fundus images cannot be collected；
* Patients with fundus diseases such as diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration, retinal vein obstruction, retinal artery obstruction, etc
Primary outcome measure(s)
- Myopic optic nerve changes — Baseline and 6 months and 1，2,3,4years
Changes in the optic nerve head morphology and blood supply which are supposed to be related with high myopia，examined by fundus photography，OCT，OCTA，etc - Progression of axial length (AL) — Baseline and 6 months and 1，2,3,4years
Subjects' axial length and its progression collected by IOL master 700 - Incidence and progression of visual field (VF) defects — Baseline and 6 months and 1，2,3,4years
Variety and progression of visual field defects collected by Humphrey 860 perimetry - Loss of best corrected visual acuity（BCVA） — Baseline and 6 months and 1，2,3,4years
Incidence of BCVA loss collected by subjective optometry - Incidence and progression of myopic maculopathy — Baseline and 6 months and 1，2,3,4years
Collected by color fundus photography and ultra-wide fundus photography
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Renmin Hospital of Wuhan University | Wuhan | Hubei | Recruiting |
More Renmin Hospital of Wuhan University trials in China
The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy
Starting soon
A Prospective Study of Cold Exposure in Patients With MASH
Active, not recruiting
Other trials for the same condition
Evaluation of Cataract Surgery Outcome
Recruiting
Shanghai High Myopia Study
Recruiting
Impact of Capsular Tension Ring Implantation on Intraocular Lens Position
Active, not recruiting
Repeated Low-Level Red-Light Therapy for Shortening Axial Length
Active, not recruiting
AI-Empowered Fundus Platform
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06162234 on ClinicalTrials.gov ↗ ← All trials in China